BeStock  
Stocks › Biotechnology › NUVB

Nuvation Bio NUVB

US equityMarket cap rank #2962Biotechnology
$3.80 −$0.01 (-0.26%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $3.80 0.00%
Open$3.77
Prev close$3.81
Day range$3.72 – $3.91
Volume6.85M
Market cap$1.34B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$44.95M+242.6% YoY
Operating profit-$42.21M+25.2% YoY
Net profit-$41.90M+24.9% YoY
Diluted EPS-$0.12+25.0% YoY
Free cash flow-$40.15M+34.1% YoY
Operating cash flow-$38.56M

Revenue, last 8 quarters

$5.7MDec '24$3.1MMar '25$4.8MJun '25$13.1MSep '25$41.9MDec '25$83.2MMar '26$31.7MJun '26$45.0MSep '26

Net profit, last 8 quarters

$-49.4MDec '24$-53.2MMar '25$-59.0MJun '25$-55.8MSep '25$-36.6MDec '25$5.4MMar '26$-62.8MJun '26$-41.9MSep '26

Diluted EPS by quarter

-0.15Dec '24-0.16Mar '25-0.17Jun '25-0.16Sep '25-0.11Dec '250.01Mar '26-0.18Jun '26-0.12Sep '26

Free cash flow by quarter

$-46.3MDec '24$-42.7MMar '25$-48.4MJun '25$-60.9MSep '25$-29.8MDec '25$5.0MMar '26$-43.2MJun '26$-40.1MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$7.9MFY24$62.9MFY25

Profitability & balance sheet

Gross margin85.8%
Operating margin-61.2%
Net margin-67.4%
Return on equity-49.1%
Return on assets-19.7%
Return on invested capital-28.7%
Current ratio7.45
Liabilities / assets70.7%
Cash & investments$663.37M
Total debt$299.66M
Net cash (debt)$363.72M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $44.95M $31.69M $83.23M $62.90M $41.87M
Total Operating Revenue $44.95M $31.69M $83.23M $62.90M $41.87M
Cost of Revenue $11.93M $9.47M $5.99M $9.30M $1.28M
Gross Profit $33.02M $22.22M $77.24M $53.60M $40.59M
Operating Expense $75.23M $73.25M $73.36M $266.67M $74.62M
Selling and Admin Expenses $42.55M $42.59M $38.31M $151.56M $40.33M
Research & Development $32.68M $30.66M $35.05M $115.11M $34.30M
Operating Profit -$42.21M -$51.04M $3.88M -$213.06M -$34.04M
Net Non-Operating Interest Income (Expense) $41,000.00 -$2.16M -$1.60M $7.75M -$1.38M
Non-Operating Interest Income $6.16M $4.60M $5.11M $21.43M $5.30M
Non-Operating Interest Expense $6.12M $6.76M $6.71M $13.68M $6.67M
Other Income (Expense) $270,000.00 -$9.64M $3.12M $689,000.00 -$1.18M
Gain on Sale of Security -$13,000.00 $9,000.00 $2.87M -$807,000.00 -$1.12M
Special Income (Charges) $0.00 -$9.47M – -$33,000.00 -$3,000.00
-Gain on Sale of Property/Plant/Equipment $0.00 $1,000.00 – -$33,000.00 -$3,000.00
Other Non-Operating Income (Expenses) $283,000.00 -$179,000.00 $243,000.00 $1.53M -$51,000.00
Pretax Profit -$41.90M -$62.84M $5.40M -$204.63M -$36.59M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit -$41.90M -$62.84M $5.40M -$204.63M -$36.59M
Profit from Continuing Operations -$41.90M -$62.84M $5.40M -$204.63M -$36.59M
Net Income to Parent Company -$41.90M -$62.84M $5.40M -$204.63M -$36.59M
Net Income to Common Stockholders -$41.90M -$62.84M $5.40M -$204.63M -$36.59M
Basic EPS -$0.12 -$0.18 $0.02 -$0.60 -$0.11
Diluted EPS -$0.12 -$0.18 $0.01 -$0.60 -$0.11
-Less:Other Special Charges – $9.47M – – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $778.39M $744.50M $610.24M $594.82M $594.82M
Total Current Assets $734.66M $726.43M $591.53M $571.52M $571.52M
Cash and Cash Equivalents & Short-Term Investments $663.37M $660.96M $533.73M $529.21M $529.21M
-Cash and Cash Equivalents $153.77M $258.60M $125.39M $164.09M $164.09M
-Short Term Investments $509.60M $402.35M $408.34M $365.13M $365.13M
Receivables $40.22M $31.71M $25.98M $19.36M $19.36M
-Accounts Receivable $36.55M $27.83M $22.72M $16.08M $16.08M
-Accrued Interest Receivable $3.68M $3.89M $3.26M $3.29M $3.29M
Inventory $15.34M $19.90M $15.84M $11.41M $11.41M
Other Current Assets $15.73M $13.86M $15.97M $11.54M $11.54M
Total Non-Current Assets $43.73M $18.07M $18.71M $23.30M $23.30M
Net PPE $16.41M $3.96M $4.13M $4.48M $4.48M
-Gross PPE $17.82M $5.29M $5.39M $5.67M $5.67M
-Accumulated Depreciation -$1.42M -$1.33M -$1.26M -$1.18M -$1.18M
Goodwill and Other Intangible Assets $19.80M $10.29M $10.76M $11.21M $11.21M
Other Non-Current Assets $7.52M $3.82M $3.82M $7.61M $7.61M
Total Liabilities $550.42M $490.64M $290.68M $289.11M $289.11M
Total Current Liabilities $98.56M $86.76M $79.52M $82.23M $82.23M
Payables $9.45M $12.09M $22.44M $9.77M $9.77M
-Accounts Payable $9.45M $12.09M $22.44M $9.48M $9.48M
Current Accrued Expenses $57.14M $45.20M $32.86M $24.90M $24.90M
Short-Term Debt and Capital Lease Obligation $6.40M $7.61M $7.63M $7.60M $7.60M
-Current Debt $5.97M $5.89M $5.79M $5.72M $5.72M
-Current Capital Lease Obligation $436,000.00 $1.72M $1.84M $1.88M $1.88M
Current Deferred Liabilities $9.06M $8.86M $8.65M $7.52M $7.52M
Other Current Liabilities $16.51M $13.00M $7.94M $12.45M $12.45M
Total Non-Current Liabilities $451.86M $403.88M $211.16M $206.88M $206.88M
Long Term Debt and Capital Lease Obligation $293.69M $244.53M $49.53M $49.75M $49.75M
-Long Term Debt $279.46M $242.62M $47.33M $47.21M $47.21M
-Long Term Capital Lease Obligation $14.23M $1.91M $2.20M $2.54M $2.54M
Non-Current Deferred Liabilities $6.65M $8.23M $9.74M $11.31M $11.31M
Other Non-Current Liabilities $151.52M $151.12M $151.89M $145.82M $145.82M
Total Equity $227.98M $253.86M $319.56M $305.72M $305.72M
Stockholders' Equity $227.98M $253.86M $319.56M $305.72M $305.72M
Capital Stock $1.45B $1.43B $1.43B $1.42B $1.42B
-Common Stock $1.45B $1.43B $1.43B $1.42B $1.42B
Retained Earnings -$1.21B -$1.17B -$1.11B -$1.12B -$1.12B
Gains/Losses Not Affecting Retained Earnings -$4.62M -$2.61M -$1.68M -$187,000.00 -$187,000.00
-Total Tax Payable – – – $286,000.00 $286,000.00
Derivative Product Liabilities – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$38.56M -$42.97M $5.07M -$173.43M -$29.73M
Net cash flow from continuing operations -$38.56M -$42.97M $5.07M -$173.43M -$29.73M
Net Income from Continuing Operations -$41.90M -$62.84M $5.40M -$204.63M -$36.59M
Gain/Loss from Continuing Operations -$242,000.00 $9.25M -$2.89M -$245,000.00 $457,000.00
Depreciation & Depletion & Amortization $578,000.00 $536,000.00 $536,000.00 $1.74M $539,000.00
Other Non-Cash Items $5.62M $5.39M $5.33M $11.08M $5.34M
Change in Working Capital -$11.53M -$5.06M -$11.50M -$11.98M -$6.28M
-Change in Receivables -$8.51M -$5.73M -$6.62M -$3.07M -$5.51M
-Change in Inventory $4.56M -$4.06M -$4.43M -$11.41M -$5.70M
-Change in Prepaid Assets -$1.87M $2.11M -$4.44M -$4.27M -$2.61M
-Change in Payables and Accrued Expense -$637,000.00 $3.93M $637,000.00 $15.48M $6.72M
-Change in Other Current Assets -$3.70M $0.00 $3.78M -$846,000.00 -$145,000.00
-Change In Other Working Capital -$1.37M -$1.31M -$426,000.00 -$7.87M $969,000.00
Net cash flow from investing -$109.34M $5.99M -$43.64M $99.52M $87.08M
Net Cash Flow from Continuing Investing Activities -$109.34M $5.99M -$43.64M $99.52M $87.08M
Net PPE Purchase and Sale -$1.59M -$254,000.00 -$48,000.00 -$354,000.00 -$89,000.00
Net Investment Purchase and Sale -$107.76M $6.25M -$43.59M $107.87M $87.17M
Financing Cash Flow $43.17M $170.53M $44,000.00 $202.54M $8.06M
Net Cash Flow from Continuing Financing Activities $43.17M $170.53M $44,000.00 $202.54M $8.06M
Net Issuance Payments Of Debt $36.57M $185.06M $0.00 $48.20M $2,000.00
Net Common Stock Issuance $0.00 – – – –
Proceeds from Stock Option Exercised $7.95M $4.75M $908,000.00 $11.42M $8.49M
Net Other Financing Charges -$1.35M -$2.15M -$864,000.00 $142.91M -$425,000.00
Ending Cash Balance $153.77M $258.60M $125.39M $164.09M $164.09M
Net Change in Cash -$104.74M $133.55M -$38.52M $128.63M $65.41M
Beginning Cash Balance $258.60M $125.39M $164.09M $35.72M $98.90M
Effect of Exchange Rate Changes -$98,000.00 -$338,000.00 -$172,000.00 -$265,000.00 -$224,000.00
Free Cash Flow -$40.15M -$43.22M $5.02M -$181.78M -$29.82M
Net Intangibles Purchase and Sale – – – -$8.00M $0.00
Net Business Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on NUVB.

Sign in to join the discussion.

Scroll to Top